DNASE1L3’s hepatic relevance extends to cancer biology, where its downregulation correlates with poor prognosis, increased angiogenesis, and immune suppression in hepatocellular carcinoma (HCC).15 The gene discussed is DNASE1L3; the disease is hepatocellular carcinoma.